Tutorials

Nifty closed at 15,436 with a gain of 260 points on a weekly basis. On the weekly chart the index has formed a long bullish candle forming higher High-low compared to previous week and has closed above previous week’s high indicating positive bias. The index is moving in a Higher Top and Higher Bottom formation on the weekly chart indicating positive bias. The chart pattern suggests that if Nifty crosses and sustains above 15500 level Read More

Petrol and Diesel Rate Today in Delhi, Bangalore, Chennai, Mumbai, Hyderabad: Prices of Petrol and Diesel were kept unchanged on Friday across major cities. Petrol in Delhi today costs Rs 93.68 per litre, while diesel in the capital city costs Rs 84.61 litre today. So far this month, rates have been hiked 14 times. Petrol price in Delhi has been increased by Rs 3.28 in May, while diesel price has surged Rs 3.88 per lire. Read More

Paytm, India’s leading digital payments provider, is aiming to raise about 218 billion rupees ($3 billion) in an initial public offering late this year, according to a person familiar with the deal, in what could be the country’s largest debut ever. The startup, backed by investors including Berkshire Hathaway Inc., SoftBank Group Corp. and Ant Group Co., plans to list in India around November and its offering could coincide with the Diwali festival season, said Read More

Asian stock markets rose Wednesday as inflation fears eased and investors looked ahead to U.S. data that are expected to show economic growth accelerating. Benchmarks in Shanghai, Tokyo, Hong Kong and Seoul advanced. Overnight, Wall Street’s S&P 500 index slipped 0.2per cent, giving up some of the previous day’s 1per cent gain. Investors worry stronger inflation might prompt governments and central banks to roll back economic stimulus. They have been reassured by comments from U.S. Read More

Natco Pharma share price hits 20 per cent upper circuit at Rs 1,188.95 apiece, also its all-time high, in intraday on BSE, after the company initiated phase III clinical trial to evaluate the efficacy and safety of Molnupiravir capsules in mild COVID-19 patients in India. Natco’s clinical trial has been planned in 32 hospitals across India. Natco Pharma stock price has surpassed its previous high of Rs 998 per share, touched in the previous session. Read More